We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA ADOPTS CDISC FORMAT FOR TRIAL DATA SUBMISSIONS
FDA ADOPTS CDISC FORMAT FOR TRIAL DATA SUBMISSIONS
July 23, 2004
The FDA has announced a new standard format that sponsors can use to submit data to the agency regarding human drug clinical trials — a format the agency hopes will lead to greater efficiencies in clinical research and FDA reviews of new drug applications.